During the past year, Oxonica focused on increasing the awareness of Optisol within the major cosmetic houses and has achieved several successful evaluations, as well as a nomination for “best new technology” at the HBA awards ceremony in New York in September 2005. The partnership with Croda is geared towards crystallizing some of these early evaluations.
Croda will provide its sales channel and technical expertise to broaden the commercialization of Optisol across a wider customer base, with an initial focus on the Americas, Europe and Australia. Croda’s global marketing network will also allow a greater market penetration of the innovative Optisol. Oxonica will work closely with Croda to provide technical and product development support.